Cargando…

G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder Cancer

Background: GNG4, a member of the G-protein γ family, is a marker of poor overall survival (OS) rates in some malignancies. However, the potential role of GNG4 in bladder cancer (BLCA) is unknown. It is also unclear whether GNG4 may be utilized as a marker to guide chemotherapy or immunotherapy. Met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Lianhui, Liu, Xuefei, Luo, Ziwei, Zhang, Chen, Wu, Chun, Mu, Weiping, Zuo, Zhixiang, Pei, Xiaoqing, Shao, Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027884/ https://www.ncbi.nlm.nih.gov/pubmed/35456499 http://dx.doi.org/10.3390/genes13040693

Ejemplares similares

The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal Adenocarcinoma
por: Liu, Xuefei, et al.
Publicado: (2022)

TIGER: A Web Portal of Tumor Immunotherapy Gene Expression Resource
por: Chen, Zhihang, et al.
Publicado: (2023)

G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Hang, et al.
Publicado: (2022)

Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?
por: Wezel, Felix, et al.
Publicado: (2017)

Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Markers, Disease
Publicado: (2023)

Differential distribution of alpha subunits and beta gamma subunits of heterotrimeric G proteins on Golgi membranes of the exocrine pancreas
Publicado: (1996)

PD1(hi) CD200(hi) CD4(+) exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial–mesenchymal transition in bladder cancer
por: Wu, Chun, et al.
Publicado: (2023)

The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy
por: Baker, Simon C., et al.
Publicado: (2022)

G protein gamma subunit, a hidden master regulator of GPCR signaling
por: Kankanamge, Dinesh, et al.
Publicado: (2022)

Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
por: Mo, Qianxing, et al.
Publicado: (2020)

Biomarkers for immunotherapy in bladder cancer: a moving target
por: Aggen, David H., et al.
Publicado: (2017)

Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer
por: Liu, Caiyun, et al.
Publicado: (2016)

Oocyte maturation in starfish is mediated by the beta gamma-subunit complex of a G-protein
Publicado: (1993)

Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy
por: Wang, Zhifeng, et al.
Publicado: (2022)

M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients
por: Li, Deng-xiong, et al.
Publicado: (2023)

Localization of a heterotrimeric G protein gamma subunit to focal adhesions and associated stress fibers
Publicado: (1994)

Farnesylation of the Transducin G Protein Gamma Subunit Is a Prerequisite for Its Ciliary Targeting in Rod Photoreceptors
por: Brooks, Celine, et al.
Publicado: (2018)

Aggregation and Prion-Inducing Properties of the G-Protein Gamma Subunit Ste18 are Regulated by Membrane Association
por: Chernova, Tatiana A., et al.
Publicado: (2020)

Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
por: Zhang, Lei, et al.
Publicado: (2022)

DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC
por: Liu, Nanbin, et al.
Publicado: (2023)

Interferon gamma in cancer immunotherapy
por: Ni, Ling, et al.
Publicado: (2018)

Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G
por: Zarogoulidis, Paul, et al.
Publicado: (2021)

Immunotherapy for bladder cancer
por: Fuge, Oliver, et al.
Publicado: (2015)

BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer Patients
por: Yue, Taohua, et al.
Publicado: (2022)

Comprehensive Evaluation of the m(6)A Regulator Prognostic Risk Score in the Prediction of Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Yu, Mingke, et al.
Publicado: (2022)

ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy
por: Sun, Jong-Mu, et al.
Publicado: (2012)

A G protein-gated K channel is activated via beta 2-adrenergic receptors and G beta gamma subunits in Xenopus oocytes
Publicado: (1995)

Simultaneous Improvement of Grain Yield and Quality through Manipulating Two Type C G Protein Gamma Subunits in Rice
por: Wu, Lian, et al.
Publicado: (2022)

Biomarkers for immunotherapy in esophageal cancer
por: Wang, Xuelian, et al.
Publicado: (2023)

Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy
por: Guo, Ziwei, et al.
Publicado: (2021)

Explore prognostic biomarker of bladder cancer based on competing endogenous network
por: Li, Faping, et al.
Publicado: (2020)

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
por: Deng, Hongyu, et al.
Publicado: (2022)

BCG in Bladder Cancer Immunotherapy
por: Jiang, Song, et al.
Publicado: (2022)

Immunotherapy plus chemotherapy showed superior clinical benefit to chemotherapy alone in advanced NSCLC patients after progression on osimertinib
por: Long, Yaping, et al.
Publicado: (2021)

Circular RNA hsa_circ_0000285 regulates the microRNA‐599/G‐protein subunit gamma 12 (miR‐599/GNG12) axis to promote glioma progression
por: Liu, Fei, et al.
Publicado: (2022)

Fatty Acid Synthase Is the Key Regulator of Fatty Acid Metabolism and Is Related to Immunotherapy in Bladder Cancer
por: Xiong, Qiao, et al.
Publicado: (2022)

Neoadjuvant and Adjuvant Chemotherapy for Variant Histology Bladder Cancers: A Systematic Review and Meta-Analysis
por: Zhu, Ziwei, et al.
Publicado: (2022)

β-Arrestin Interacts with the Beta/Gamma Subunits of Trimeric G-Proteins and Dishevelled in the Wnt/Ca(2+) Pathway in Xenopus Gastrulation
por: Seitz, Katharina, et al.
Publicado: (2014)

A novel role for the Fc receptor gamma subunit: enhancement of Fc gamma R ligand affinity
Publicado: (1996)

Preoperative Serum Gamma-Glutamyltransferase as a Prognostic Biomarker in Patients Undergoing Radical Cystectomy for Bladder Cancer
por: Su, Shiqiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1d63tf1nop56lj9u96nuq85e9r